Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: ZXE7F2GMJJ

Structure

InChI Key BMMXYEBLEBULND-UHFFFAOYSA-N
Smile COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1
InChI
InChI=1S/C28H25F3N6O2/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36/h3-8,13-16,32H,9-12H2,1-2H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C28H25F3N6O2
Molecular Weight 534.54
AlogP 4.38
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 77.21
Molecular species BASE
Aromatic Rings 5.0
Heavy Atoms 39.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR PI3-kinase class I inhibitor PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- 38 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials
Hamartoma Syndrome, Multiple 1 D006223 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 71967
ChEMBL CHEMBL3218578
EPA CompTox DTXSID60238600
FDA SRS ZXE7F2GMJJ
Guide to Pharmacology 7951
SureChEMBL SCHEMBL146939
ZINC ZINC000073069304
ChEBI 71953
ChEMBL CHEMBL3545096
FDA SRS 4YG62LG876
SureChEMBL SCHEMBL996046